Coaxing a Pyridine Nucleus To Give Up Its Aromaticity:  Synthesis and Pharmacological Characterization of Novel Conformationally Restricted Analogues of Nicotine and Anabasine#

Journal of Medicinal Chemistry
2004.0

Abstract

A series of novel nicotine and anabasine related conformationally restricted compounds including those with pi-bonds in the connecting tether were synthesized following the hitherto unprecedented phenylsulfanyl group assisted generation of pyridine o-quinodimethane intermediates and their trapping by an intramolecular Diels-Alder reaction. Pharmacological characterization of some of these analogues at activating alpha3beta4 nAChRs was investigated, and constrained anabasine analogues 35 and 43 as well as constrained nicotine analogue 42 were found to exhibit moderately potent nicotinic agonist activity. Of special note is the fact that the pyrrolidinic nitrogen in these compounds is bound to a carbomethoxy group and, therefore, is not free to be protonated unlike all the known analogues of nicotine and anabasine, specifically designed as nAChRs agonists/antagonists. The structure-activity relationship studies indicate that when pi-cation interaction is absent, the position of chlorine atom in the pyridine ring and steric bulk at the connecting tether between the pyridine and pyrrolidine ring of the constrained nicotinic ligands are important descriptors for their binding affinity at alpha4beta2 and alpha3beta4 nAChRs as well as the subtype selectivity issue. These findings are likely to improve our understanding of the structural requirements for selectivity, which, at present, is probably the most important goal in the field of nicotinic ligands.

Knowledge Graph

Similar Paper

Coaxing a Pyridine Nucleus To Give Up Its Aromaticity:  Synthesis and Pharmacological Characterization of Novel Conformationally Restricted Analogues of Nicotine and Anabasine<sup>#</sup>
Journal of Medicinal Chemistry 2004.0
Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype
European Journal of Medicinal Chemistry 2016.0
Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
Chemistry and Pharmacological Characterization of Novel Nitrogen Analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(Azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-Nicotinic Acetylcholine Receptor-Selective Partial Agonists
Journal of Medicinal Chemistry 2010.0
Conformationally Constrained Nicotines:  Polycyclic, Bridged, and Spiro-Annulated Analogues as Novel Ligands for the Nicotinic Acetylcholine Receptor
Journal of Medicinal Chemistry 2002.0
Design, Synthesis, and Preliminary Pharmacological Evaluation of New Quinoline Derivatives as Nicotinic Ligands
Journal of Medicinal Chemistry 2007.0
Conformationally restricted analogues of nicotine and anabasine
Bioorganic &amp; Medicinal Chemistry Letters 1998.0
Structure–activity relationships of N-substituted ligands for the α7 nicotinic acetylcholine receptor
Bioorganic &amp; Medicinal Chemistry Letters 2010.0
Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist
Bioorganic &amp; Medicinal Chemistry Letters 1998.0
Tying up Nicotine: New Selective Competitive Antagonist of the Neuronal Nicotinic Acetylcholine Receptors
ACS Medicinal Chemistry Letters 2015.0